Use of Fecal Microbial Transplantation for Immune Checkpoint Inhibitor Colitis

Immune checkpoint inhibitors (ICIs) can result in immune-related adverse events which require rapid identification and treatment. Gastrointestinal immune-related adverse events are among the most frequent and severe of these events. ICI colitis can be refractory to current therapies such as corticos...

Descripción completa

Detalles Bibliográficos
Autores principales: Fasanello, Micaela K., Robillard, Kevin T., Boland, Patrick M., Bain, Andrew J., Kanehira, Kazunori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224717/
https://www.ncbi.nlm.nih.gov/pubmed/32548190
http://dx.doi.org/10.14309/crj.0000000000000360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224717/
https://www.ncbi.nlm.nih.gov/pubmed/32548190
http://dx.doi.org/10.14309/crj.0000000000000360

Ejemplares similares